WASHINGTON, April 10 (Reuters) - A Merck & Co. Inc. (MRK.N: Quote, Profile , Research) study showed the risk of heart attacks and other cardiovascular problems for patients who took pain reliever Arcoxia was similar to that with the older drug diclofenac, U.S. regulatory reviewers said in documents made public on Tuesday.
